Sultamicillin

This classification denotes an anti-bacterial agent and ampicillin with the molecular formula C25H30N4O9S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65DT0ML581, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (((3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-yl)carbonyl)oxy)methyl ester, s,s-dioxide, (2s-(2alpha(2r*,5s*),5alpha,6beta(s*)))- but generally known as sultamicillin, which bears US NIH Compound Identifier 53512. European Medicines Agency schedules Sultamicillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10761MIG. World Health Organization schedules sultamicillin in its Anatomical Therapeutic Chemical (ATC) Classification. SULTAMICILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sultamicillin under HS 29411090 and SITC 54131. As of Q4 2014, SULTAMICILLIN remains the US FDA Preferred Term for this commodity. SMILES: S1(=O)(=O)C(C(N2C1CC2=O)C(=O)OCOC(=O)C1N2C(SC1(C)C)C(NC(=O)C(N)C1CCCCC1)C2=O)(C)C.